Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-098575
Filing Date
2024-08-19
Accepted
2024-08-19 16:30:30
Documents
88
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A eldn-20231231.htm   iXBRL 10-K/A 3063060
2 EX-23.1 eldn-ex23_1.htm EX-23.1 5709
3 EX-31.5 eldn-ex31_5.htm EX-31.5 16032
4 EX-31.6 eldn-ex31_6.htm EX-31.6 16275
5 EX-32.3 eldn-ex32_3.htm EX-32.3 8356
6 EX-32.4 eldn-ex32_4.htm EX-32.4 8199
7 GRAPHIC img116206746_0.jpg GRAPHIC 868165
8 GRAPHIC img116206746_1.jpg GRAPHIC 337080
9 GRAPHIC img116206746_2.jpg GRAPHIC 142341
10 GRAPHIC img116206746_3.jpg GRAPHIC 119803
  Complete submission text file 0000950170-24-098575.txt   15985409

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20231231.xsd EX-101.SCH 1492866
90 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20231231_htm.xml XML 2710710
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36620 | Film No.: 241221021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)